Knockdown of Orphan Transporter SLC22A18 Impairs Lipid Metabolism and Increases Invasiveness of HepG2 Cells.
Shingo ItoGentaro HondaYu FujinoSeiryo OgataMio Hirayama-KurogiSumio OhtsukiPublished in: Pharmaceutical research (2019)
Our results suggest that suppression of SLC22A18 decreased the supply of intracellular free fatty acids from triglyceride-rich lipid droplets by impairing the lysosomal/autophagy degradation pathway and reduced the invasive activity of HepG2 cells by decreasing IGFBP-1 expression.